Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now early-phase tilt

Bulimia Nervosa: early-phase trial registry

13 of 24 indexed Bulimia Nervosa trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #686 of 28,707 conditions by registered trial count.

24 US clinical trials · 13 currently recruiting · #686 of 28,707 conditions by registered trial count

Bulimia Nervosa: 24 US clinical trials tracked, 13 recruiting.

Bulimia Nervosa is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Diego, running 6 of these trials.

Enrollment posture brief

Registry condition bulimia-nervosa

OPEN 13 | RECR 54% | LATE 0 | EARLY 1 | RANK #686 | SPON 6

Nearest open-share peer: Diabetic Kidney Disease (54% recruiting · 24 trials)

Bulimia Nervosa (this)54%Aplastic Anemia37.5%Behavior37.5%Allergic Rhinitis8.3%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Bulimia Nervosa

Bulimia Nervosa lists 13 open slots (54% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bulimia Nervosa on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bulimia Nervosa is recruiting above its size-band peers.

    13 of 24 indexed trials (54.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Bulimia Nervosa research.

    University of California, San Diego accounts for 6 of 24 trials (25%). 13 distinct sponsors appear on at least one study for this condition label.

  3. Most Bulimia Nervosa trials plan to enrol fewer than 100 people.

    Median target enrolment is 61 among the 24 trials that report a genuine target (sentinel values excluded). 16 of those (66.7%) plan for fewer than 100 participants.

  4. Bulimia Nervosa research is mostly interventional.

    17 interventional and 7 observational studies make up this index (70.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Open and recent trials

24 total, page 1 of 1

RECRUITING 20,000 participants

Eating Disorders Genetics Initiative 2

University of North Carolina, Chapel Hill

NCT06594913

RECRUITING NA 264 participants

Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Drexel University

NCT05473013

RECRUITING 252 participants

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

University of California, San Diego

NCT05056597

RECRUITING NA 150 participants

Changes in Inhibition and Valuation After Eating

Icahn School of Medicine at Mount Sinai

NCT05995496

RECRUITING NA 144 participants

Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans

VA Connecticut Healthcare System

NCT05304104

RECRUITING 100 participants

Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa

University of Minnesota

NCT04917068

RECRUITING 78 participants

Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa

University of California, San Diego

NCT06566612

RECRUITING NA 60 participants

Targeting Social Function in Anxiety and Eating Disorders

University of Texas Southwestern Medical Center

NCT06198023

RECRUITING Early Phase 1 60 participants

Naltrexone Neuroimaging in Teens With Eating Disorders

Children's Mercy Hospital Kansas City

NCT05509257

RECRUITING NA 30 participants

Neurofeedback During Eating for Bulimia Nervosa

Icahn School of Medicine at Mount Sinai

NCT05614024

RECRUITING NA 26 participants

Relationships Between Exercise and Appetite in Women With Loss of Control Eating

Ohio University

NCT06602973

RECRUITING NA 20 participants

Therapeutic Ketogenic Diet in Anorexia Nervosa

University of California, San Diego

NCT06000774

RECRUITING NA 20 participants

Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

Milton S. Hershey Medical Center

NCT07237607

ACTIVE NOT RECRUITING NA 410 participants

Effects of Negative Affect in Individuals With Binge Eating Episodes

University of California, San Diego

NCT03393039

ACTIVE NOT RECRUITING NA 76 participants

Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating

Drexel University

NCT05937243

ACTIVE NOT RECRUITING NA 40 participants

Ketone Supplementation in Eating Disorders

University of California, San Diego

NCT05507008

COMPLETED 17,991 participants

Eating Disorders Genetics Initiative

University of North Carolina, Chapel Hill

NCT04378101

COMPLETED 89 participants

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

University of California, San Diego

NCT02997475

COMPLETED 61 participants

Examining Common Substrates of Eating and Alcohol Use Disorders

New York State Psychiatric Institute

NCT01172210

COMPLETED NA 32 participants

App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

Yeshiva University

NCT05753410

COMPLETED NA 30 participants

Using Continuous Glucose Monitoring to Detect and Intervene on Maintenance Factors for Trans-diagnostic Binge Eating Pathology

Drexel University

NCT04126694

COMPLETED NA 25 participants

Engaging Latino Families in Eating Disorders Treatment

Mae Lynn Reyes-Rodriguez, PhD

NCT01470508

COMPLETED NA 10 participants

Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder

New York State Psychiatric Institute

NCT00320047

COMPLETED NA 9 participants

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

Milton S. Hershey Medical Center

NCT02382848

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Bulimia Nervosa records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Eating disorder diagnosis group Other
2 trials
Placebo Drug
2 trials
Cognitive Behavioral Therapy with Family Enhancement Behavioral
1 trials
CBT with smartphone application SenseSupport Behavioral
1 trials
Mindful Courage Behavioral
1 trials
Kenetik Ketone Drink Dietary supplement
1 trials
Advanced Digital Data Sharing (ADDS) with Coaches Behavioral
1 trials
Just-in-time, adaptive intervention (JITAIs) system Behavioral
1 trials

US sites by state

Facility locations filed on Bulimia Nervosa trials. A trial with sites in several states counts in each.

California 6 trials
Pennsylvania 5 trials
New York 5 trials
North Carolina 3 trials
Texas 1 trials
Ohio 1 trials
Missouri 1 trials
Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Bulimia Nervosa page

24 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bulimia Nervosa condition card totals 24 registered trials; most-linked intervention Eating disorder diagnosis group; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.